HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA
INBC 2023

Transcranial Pulse Stimulation (TPS) – advancements, applications, and current status

Speaker at Neurology Conferences - Thi Lan Marina Freedman
STORZ Medical AG, Switzerland
Title : Transcranial Pulse Stimulation (TPS) – advancements, applications, and current status

Abstract:

Shock waves, single acoustic mechanical pulses utilized in medical treatments since 1980, have demonstrated therapeutic effects in localized tissue regions. Research indicates that shock waves stimulate mechanotransduction, triggering the release of Growth Factors (VEGF) and Nitric Oxide (NO). These mechanisms enhance cerebral blood flow, promote angiogenesis, and facilitate neural regeneration.

Transcranial Pulse Stimulation (TPS®) utilizes low energy shock waves, that are non-invasively transmitted through the skull into the brain regions affected by Alzheimer's disease, up to 8 centimeters deep. The NEUROLITH® device, CE-approved since 2018, offers TPS treatment for Alzheimer's dementia symptoms. TPS treatment typically involves a series of six sessions within two weeks, with each session lasting approximately 30 minutes. Follow-up sessions are recommended on individual basis after 4 to 8 weeks. The energy transmission is visually displayed, allowing the operator and patient to track the precise brain area targeted during the treatment.

The utilization of shock waves in TPS represents an innovative approach for addressing Alzheimer's disease symptoms. By stimulating growth factors and enhancing blood flow, TPS aims to promote the formation of new blood vessels and facilitate neural regeneration. Recent studies show promising outcomes of TPS in improving cognition among individuals with Alzheimer's disease. Conducted TPS surveys provide insights into the current applications and observed results, contributing to further understanding its application range and potential effectiveness. Ongoing research efforts are dedicated to further exploring the effects of TPS and its efficacy in improving cognition and enhancing quality of life in individuals with Alzheimer's disease. By studying the application of TPS and evaluating its effects, researchers and medical professionals aim to refine treatment protocols and optimize patient outcomes.

Biography:

Thi-Lan Freedman, Business Development Manager in Neurology, has been dedicated to the development, promotion, and scientific progress of NEUROLITH at Storz Medical for the past three years. With a background in Business, she pursued her studies in Bochum and Shanghai. Since 2013, she has been actively involved in the field of Rehabilitation and Medicine, leveraging her expertise to drive advancements in modern treatment approaches. Through collaborations and market analysis, Thi-Lan Freedman ensures continuous improvement and impactful advancements in NEUROLITH with Transcranial Pulse Stimulation (TPS).

Watsapp